Safety and efficacy of human apotransferrin infusion in patients with β-thalassemia intermedia: the AIM study.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-01-01 DOI:10.3324/haematol.2024.285045

Kadère Konté, Dorine W Swinkels, Ilona Kleine Budde, Erfan Nur, Bart J Biemond

引用次数: 0

查看原文本刊更多论文

人源转铁蛋白输注对中型β地中海贫血患者的安全性和有效性：AIM 研究。

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.